comparemela.com

Latest Breaking News On - Flebogamma immune globulin intravenous - Page 1 : comparemela.com

Deutsche Bank Aktiengesellschaft Lowers Grifols (NASDAQ:GRFS) to Sell

Grifols (NASDAQ:GRFS – Get Free Report) was downgraded by investment analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “sell” rating in a report issued on Tuesday, Marketbeat Ratings reports. Separately, JPMorgan Chase & Co. increased their target price on Grifols from $10.00 to $10.50 and gave the company a “neutral” rating in […]

Contrasting Grifols (NASDAQ:GRFS) and Tango Therapeutics (NASDAQ:TNGX)

Tango Therapeutics (NASDAQ:TNGX – Get Free Report) and Grifols (NASDAQ:GRFS – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk. Profitability This table compares Tango Therapeutics and Grifols’ net […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.